Skip to content
Colorectal Cancer Clinical Trials

Rhode Island

Colorectal cancer clinical trials in Rhode Island

9 colorectal cancer studies are recruiting participants at sites in 3 cities across Rhode Island as of November 16, 2026, according to ClinicalTrials.gov.

Call (888) 385-9581
  • No cost to ask
  • Taking part is voluntary
  • Studies are independently reviewed

Every Rhode Island city with a recruiting study

Providence (8), Warwick (1), Westerly (1).

The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.

Recently updated studies in Rhode Island

Basic details from each study's public record. Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.

  1. Phase III Study of Ivonescimab or Bevacizumab Combined With FOLFOX in Patients With Metastatic Colorectal Cancer

    • Phase 3
    • Ages 18 and older
    • All sexes
    Sponsor
    Summit Therapeutics
    Recruiting in
    Providence
    Registry record
    NCT07228832 · updated
  2. Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps

    • No phase
    • Ages 45 to 70
    • All sexes
    Sponsor
    NRG Oncology
    Recruiting in
    Providence
    Registry record
    NCT05080673 · updated
  3. Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease

    • Phase 2/3
    • Ages 18 and older
    • All sexes
    Sponsor
    NRG Oncology
    Recruiting in
    Providence · Westerly
    Registry record
    NCT05174169 · updated
  4. Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

    • Observational
    • Ages 40 to 75
    • All sexes
    Sponsor
    Alliance for Clinical Trials in Oncology
    Recruiting in
    Warwick
    Registry record
    NCT05334069 · updated
  5. Study of Safety and Tolerability of BCA101 Monotherapy and in Combination Therapy in Patients With EGFR-driven Advanced Solid Tumors

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Bicara Therapeutics
    Recruiting in
    Providence
    Registry record
    NCT04429542 · updated
  6. TLR9 Immunotherapy for Peritoneal Carcinomatosis

    • Phase 1
    • Ages 18 and older
    • All sexes
    Sponsor
    Brown University
    Recruiting in
    Providence
    Registry record
    NCT07658196 · updated
  7. Y-90, Capecitabine, and Atezolizumab for Oligometastatic CRC

    • Phase 2
    • Ages 18 and older
    • All sexes
    Sponsor
    Brown University
    Recruiting in
    Providence
    Registry record
    NCT06555133 · updated
  8. A Study of Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy

    • Phase 1/2
    • Ages 18 and older
    • All sexes
    Sponsor
    7 Hills Pharma, LLC
    Recruiting in
    Providence
    Registry record
    NCT06362369 · updated
  9. SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

    • Observational
    • All ages
    • All sexes
    Sponsor
    Massive Bio, Inc.
    Recruiting in
    Providence
    Registry record
    NCT03452774 · updated

Source: ClinicalTrials.gov. Data processed . See every colorectal cancer study recruiting in Rhode Island on ClinicalTrials.gov.

Ask about studies in Rhode Island

Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.

How should we reach you?
Add a message or the best time to reach you (optional)

Please do not include detailed medical information.

Before you contact a study

About these listings

These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 16, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded.

Colorectal Cancer Clinical Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.

Sources and further reading

Ask about a study

A coordinator will contact you. Asking does not commit you to anything.

Call (888) 385-9581

or send a short form

How should we reach you?

Call